Detalhe da pesquisa
1.
CAR-T cell expansion platforms yield distinct T cell differentiation states.
Cytotherapy
; 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38625071
2.
Group O plasma as a media supplement for CAR-T cells and other adoptive T-cell therapies.
Transfusion
; 60(5): 1004-1014, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32167176
3.
Production of a cellular product consisting of monocytes stimulated with Sylatron® (Peginterferon alfa-2b) and Actimmune® (Interferon gamma-1b) for human use.
J Transl Med
; 17(1): 82, 2019 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30871636
4.
Enhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modules.
J Transl Med
; 16(1): 13, 2018 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29368612
5.
T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma.
Blood
; 128(13): 1688-700, 2016 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27412889
6.
Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies.
Blood
; 128(4): 519-28, 2016 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27226436
7.
Counter-flow elutriation of clinical peripheral blood mononuclear cell concentrates for the production of dendritic and T cell therapies.
J Transl Med
; 12: 241, 2014 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-25223845
8.
Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation.
Blood
; 119(12): 2956-9, 2012 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22289893
9.
Optimization of anti-CD19 CAR T cell production for treatment of patients with chronic lymphocytic leukemia.
Mol Ther Methods Clin Dev
; 32(1): 101212, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38455264
10.
Differential gene expression profile of first-generation and second-generation rapamycin-resistant allogeneic T cells.
Cytotherapy
; 15(5): 598-609, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23352462
11.
Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignancies.
Biol Blood Marrow Transplant
; 17(12): 1855-61, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21684344
12.
Immune reconstitution in recipients of photodepleted HLA-identical sibling donor stem cell transplantations: T cell subset frequencies predict outcome.
Biol Blood Marrow Transplant
; 17(12): 1846-54, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21684345
13.
Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individuals.
Hum Gene Ther
; 16(9): 1065-74, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16149905
14.
Minimal residual disease detection in breast cancer: improved sensitivity using cytokeratin 19 and epidermal growth factor receptor RT-PCR.
Int J Oncol
; 24(4): 861-7, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15010823
15.
Phase I trial of adoptive cell transfer with mixed-profile type-I/type-II allogeneic T cells for metastatic breast cancer.
Clin Cancer Res
; 17(21): 6878-87, 2011 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21948234
16.
A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique.
Blood
; 111(8): 4392-402, 2008 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17878399
17.
Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells.
NMR Biomed
; 18(8): 553-9, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16229060